![Joel Naor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joel Naor
Geen lopende functies
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Quinton Oswald | M | - | 2 jaar | |
Susan Orr | M | - | 2 jaar | |
Anshul Thakral | M | 46 | 1 jaar | |
Bruno Gagnon | M | - | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Michael Sistenich | M | 49 | 8 jaar | |
Timothy Morris | M | 62 | 1 jaar | |
Mark Blumenkranz | M | 73 |
MacuSight, Inc.
![]() MacuSight, Inc. Pharmaceuticals: MajorHealth Technology MacuSight, Inc. develops and manufactures pharmaceuticals products. The firm engages in developing therapeutics for the treatment of severe ocular diseases and conditions. It offers sirolimus, a therapeutic for the treatment and prevention of wet age-related macular degeneration, as well as for the treatment of diabetic macular edema; and related compounds and other select therapeutics in the eye, as well as minimally-invasive ocular formulations. The company was founded in 2003 and is headquartered in Union City, CA. | - |
Marcel Konrad | M | 49 |
Santen, Inc.
![]() Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | 5 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Australië | 6 | 75.00% |
Verenigde Staten | 2 | 25.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties